AnaptysBio Inc (ANAB)
Healthcare
Biotechnology
53.40 $
-3.1%
vs. previous close
Closing price · As of: 31. Jul 2026
AnaptysBio Inc (ANAB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -26 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -25 | -36 | -34 | -37 | -21 | -10 | -67 | -11 | -40 | -27 | 98 | -26 | 4.5 | |
| 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 2.4 | |
| 8.4 | 7.8 | 8.1 | 10 | 7.5 | 8.2 | 8.2 | 9.2 | 9.2 | 9.2 | 8.5 | 14 | 41 | |
| 8.4 | 9.2 | – | – | – | – | – | – | – | – | – | – | – | |
| 3.2 | -9.0 | -2.7 | -7.4 | 8.7 | -1.3 | -69 | 2.5 | -29 | -74 | 20 | -7.7 | -91 | |
| 0.2 | 0.2 | 0.3 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| -20 | 31 | 49 | 69 | -2.4 | 59 | -29 | 15 | 36 | 103 | 74 | 35 | 248 | |
| 2.2 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -12 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.5 | -4.4 | -51 | -9.7 | -3.4 | 0.0 | -64 | |
| -13 | -3.1 | -5.2 | -14 | 42 | 71 | 28 | -29 | -50 | -10 | -43 | 1.2 | -103 | |
| -59 | -8.9 | 9.7 | 18 | 18 | 120 | -69 | -24 | -54 | 66 | 128 | 10 | 150 | |
| -26 | -37 | -35 | -37 | -21 | -10 | -67 | -11 | -40 | -27 | 98 | -26 | 4.4 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.